<SEC-DOCUMENT>0001638599-16-000697-index.html : 20160229
<SEC-HEADER>0001638599-16-000697.hdr.sgml : 20160229
<ACCEPTANCE-DATETIME>20160229172329
ACCESSION NUMBER:		0001638599-16-000697
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160225
FILED AS OF DATE:		20160229
DATE AS OF CHANGE:		20160229

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NAVIDEA BIOPHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000810509
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				311080091
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147937500

	MAIL ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEOPROBE CORP
		DATE OF NAME CHANGE:	19940714

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LARSON BRENT L
		CENTRAL INDEX KEY:			0001195766

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35076
		FILM NUMBER:		161469675

	MAIL ADDRESS:	
		STREET 1:		425 METRO PLACE NORTH
		STREET 2:		STE 400
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4_3736.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: doc4_3736.html

Document 1 - RAW XML: doc4_3736.xml

</DOCUMENT>
</SEC-DOCUMENT>